KEGG   DRUG: Zansecimab
Entry
D11904                      Drug                                   
Name
Zansecimab (USAN)
Formula
C6438H9888N1704O2034S48
Exact mass
145150.9278
Mol weight
145240.7137
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYSFT DYNMVWVRQA PGQGLEWMGY IDPYNGGTGY
NQKFEGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARTR DRYDVWYFDV WGQGTLVTVS
SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEAAGGPS
VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST
YRVVSVLTVL HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT
KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE
GNVFSCSVMH EALHNHYTQK SLSLSLG
(Light chain)
DIQMTQSPSS VSASVGDRVT ITCKASQDVY IAVAWYQQKP GKAPKLLIYW ASTRDTGVPS
RFSGSGSGTD FTLTISSLQP EDFATYYCHQ YSSYPPTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H135-L214, H148-H204, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'96, H'135-L'214, H'148-H'204, H'262-H'322, H'368-H'426, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Anti-angiopoietin 2 antibody
  Type
Monoclonal antibody
Comment
Enhancing endothelial stabilization and prevention of acute respiratory distress syndrome (ARDS) in patients with COVID-19
Target
ANGPT2 [HSA:285] [KO:K05466]
  Pathway
hsa04010  MAPK signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Growth factors (RTK-binding)
    ANGPT2
     D11904  Zansecimab (USAN)
Other DBs
CAS: 2415205-37-5
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system